ClinConnect ClinConnect Logo
Search / Trial NCT07041554

Cardiovascular Risk Factors and Physical Activity in Chronic Kidney Patients on Peritoneal Dialysis

Launched by DOKUZ EYLUL UNIVERSITY · Jun 18, 2025

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

Cardiovascular Risk Factors Physical Activity Arterial Stiffness Accelerometer Peritoneal Dialysis

ClinConnect Summary

This clinical trial is looking at how heart health risks relate to physical activity in people with chronic kidney disease who are receiving a type of treatment called peritoneal dialysis. Peritoneal dialysis is a way to clean the blood when the kidneys aren’t working well. The study aims to understand if being more active can help reduce risks like stiff arteries, which can affect heart health.

People who might join this study are adults aged 18 or older who have chronic kidney disease and have been on peritoneal dialysis for at least three months. To take part, participants need to be able to walk on their own and not have serious health problems that would make it hard to wear a small device (an accelerometer) used to track their activity. Those with memory issues or recent leg injuries may not be eligible. If you join, you can expect to have your physical activity measured and your heart health evaluated to see how they are connected. This study is not yet recruiting participants but aims to help improve care and advice for people with kidney disease in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosed with chronic kidney disease
  • Peritoneal dialysis treatment for at least three months
  • Age ≥ 18
  • Exclusion Criteria:
  • Mini Mental Test Score \< 24
  • Serious cardiovascular, pulmonary, or neurological conditions that make it impossible to wear an accelerometer
  • Inability to walk independently
  • Conditions affecting participation in daily life due to lower limb injury or surgery

About Dokuz Eylul University

Dokuz Eylul University is a prominent educational institution located in İzmir, Turkey, recognized for its commitment to advancing medical research and clinical innovation. As a clinical trial sponsor, the university leverages its extensive academic resources and expertise to conduct cutting-edge research aimed at improving patient outcomes. With a focus on interdisciplinary collaboration and adherence to ethical standards, Dokuz Eylul University strives to contribute valuable insights to the medical community while fostering the development of new therapeutic interventions.

Locations

İzmir, , Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported